Cargando…

Natriuretic peptides in cardiovascular diseases

The natriuretic peptide family comprises atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), C-type natriuretic peptide (CNP), dendroaspis natriuretic peptide (DNP), and urodilatin. The activities of natriuretic peptides and endothelins are strictly associated with each other. ANP and...

Descripción completa

Detalles Bibliográficos
Autores principales: Piechota, Mariusz, Banach, Maciej, Jacoń, Anna, Rysz, Jacek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SP Versita 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275881/
https://www.ncbi.nlm.nih.gov/pubmed/17965966
http://dx.doi.org/10.2478/s11658-007-0046-6
_version_ 1783377899695374336
author Piechota, Mariusz
Banach, Maciej
Jacoń, Anna
Rysz, Jacek
author_facet Piechota, Mariusz
Banach, Maciej
Jacoń, Anna
Rysz, Jacek
author_sort Piechota, Mariusz
collection PubMed
description The natriuretic peptide family comprises atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), C-type natriuretic peptide (CNP), dendroaspis natriuretic peptide (DNP), and urodilatin. The activities of natriuretic peptides and endothelins are strictly associated with each other. ANP and BNP inhibit endothelin-1 (ET-1) production. ET-1 stimulates natriuretic peptide synthesis. All natriuretic peptides are synthesized from polypeptide precursors. Changes in natriuretic peptides and endothelin release were observed in many cardiovascular diseases: e.g. chronic heart failure, left ventricular dysfunction and coronary artery disease.
format Online
Article
Text
id pubmed-6275881
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher SP Versita
record_format MEDLINE/PubMed
spelling pubmed-62758812018-12-10 Natriuretic peptides in cardiovascular diseases Piechota, Mariusz Banach, Maciej Jacoń, Anna Rysz, Jacek Cell Mol Biol Lett Review Article The natriuretic peptide family comprises atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), C-type natriuretic peptide (CNP), dendroaspis natriuretic peptide (DNP), and urodilatin. The activities of natriuretic peptides and endothelins are strictly associated with each other. ANP and BNP inhibit endothelin-1 (ET-1) production. ET-1 stimulates natriuretic peptide synthesis. All natriuretic peptides are synthesized from polypeptide precursors. Changes in natriuretic peptides and endothelin release were observed in many cardiovascular diseases: e.g. chronic heart failure, left ventricular dysfunction and coronary artery disease. SP Versita 2008-04-10 /pmc/articles/PMC6275881/ /pubmed/17965966 http://dx.doi.org/10.2478/s11658-007-0046-6 Text en © Versita 2007
spellingShingle Review Article
Piechota, Mariusz
Banach, Maciej
Jacoń, Anna
Rysz, Jacek
Natriuretic peptides in cardiovascular diseases
title Natriuretic peptides in cardiovascular diseases
title_full Natriuretic peptides in cardiovascular diseases
title_fullStr Natriuretic peptides in cardiovascular diseases
title_full_unstemmed Natriuretic peptides in cardiovascular diseases
title_short Natriuretic peptides in cardiovascular diseases
title_sort natriuretic peptides in cardiovascular diseases
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275881/
https://www.ncbi.nlm.nih.gov/pubmed/17965966
http://dx.doi.org/10.2478/s11658-007-0046-6
work_keys_str_mv AT piechotamariusz natriureticpeptidesincardiovasculardiseases
AT banachmaciej natriureticpeptidesincardiovasculardiseases
AT jaconanna natriureticpeptidesincardiovasculardiseases
AT ryszjacek natriureticpeptidesincardiovasculardiseases